GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dali Pharmaceutical Co Ltd (SHSE:603963) » Definitions » Marketable Securities

Dali Pharmaceutical Co (SHSE:603963) Marketable Securities : ¥0.00 Mil (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Dali Pharmaceutical Co Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Dali Pharmaceutical Co's Marketable Securities for the quarter that ended in Sep. 2024 was ¥0.00 Mil.

Dali Pharmaceutical Co's annual Marketable Securities increased from Dec. 2021 (¥132.44 Mil) to Dec. 2022 (¥229.23 Mil) but then declined from Dec. 2022 (¥229.23 Mil) to Dec. 2023 (¥206.74 Mil).


Dali Pharmaceutical Co Marketable Securities Historical Data

The historical data trend for Dali Pharmaceutical Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dali Pharmaceutical Co Marketable Securities Chart

Dali Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 225.23 240.75 132.44 229.23 206.74

Dali Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 206.19 206.74 175.73 80.78 -

Dali Pharmaceutical Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Dali Pharmaceutical Co  (SHSE:603963) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


Dali Pharmaceutical Co Marketable Securities Related Terms

Thank you for viewing the detailed overview of Dali Pharmaceutical Co's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Dali Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 118, Huancheng West Road, Yunnan Province, Xiaguan Town, Dali, CHN, 671000
Dali Pharmaceutical Co Ltd operates in the pharmaceutical manufacturing industry. It is engaged in the research and development and production of Chinese and Western medicine injection products. The company's main products are Zhongjing Brand Xingnaojing Injection, Shenmai Injection, Astragalus Injection, Brighten A Injection and Cell Diphosphocholine injection.
Executives
Wu Pei Rong senior management
Yang Jun Xiang Directors, senior managers
Yang Jun Wei Director

Dali Pharmaceutical Co Headlines

No Headlines